Business Wire CEO: Reported Fake Release To FBI
21 Giugno 2010 - 4:33PM
Dow Jones News
News release service Business Wire has reported a fake press
release involving Javelin Pharmaceuticals Inc. (JAV) that ran on
its service Friday night to the Federal Bureau of Investigation,
Business Wire Chief Executive Cathy Tamraz said.
The FBI couldn't immediately be reached. Tamraz said her firm
has reported the case to the New York bureau of the FBI, and the
case is being treated as a "criminal investigation."
Javelin Pharmaceuticals Monday morning announced that on June 18
Business Wire inadvertently issued a hoax press release titled "US
Supreme Court split -- rules in favor of Big Pharma" that falsely
identified Javelin Pharmaceuticals as the issuer of the
information. The information in the hoax release was false,
Javelin's statement said. Business Wire received the hoax release
from an unknown third party, purporting to be an authorized
representative of the company, Javelin's Monday statement said.
-By Anjali Cordeiro, Dow Jones Newswires; 212-416-2200;
anjali.cordeiro@dowjones.com
Grafico Azioni Javelin Pharmaceuticals (AMEX:JAV)
Storico
Da Gen 2025 a Feb 2025
Grafico Azioni Javelin Pharmaceuticals (AMEX:JAV)
Storico
Da Feb 2024 a Feb 2025
Notizie in Tempo Reale relative a Javelin Pharmaceuticals (Borsa Americana (AMEX)): 0 articoli recenti
Più Javelin Pharmaceuticals Inc. Articoli Notizie